[Drug-induced pulmonary edema].
Kubo
Keishi
K
Department of Medicine, Shinshu University School of Medicine.
D000638:Amiodarone / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D003937:Diagnosis, Differential; D064420:Drug-Related Side Effects and Adverse Reactions; D000077156:Gefitinib; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009638:Norepinephrine / Q000009:adverse effects; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D011799:Quinazolines / Q000009:adverse effects; D012121:Respiration, Artificial; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011799:Quinazolines; D000638:Amiodarone; D001241:Aspirin; D000077156:Gefitinib; D009638:Norepinephrine